Webinar Wednesdays in future – DHACA, AHSN Network and the Royal Society of Medicine in combination!
As hinted at in an earlier newsletter, DHACA and the AHSN Network are now combining with the RSM to produce a single webinar most Wednesdays. The plus points are that the RSM can attract the very best speakers from around the world, and the Webinars themselves will earn attendees one CPD point/event. The downside is that that has to be paid for, so the RSM will charge DHACA members £10/webinar provided they use the individual code to give a 50% discount to the usual price of £20 for non-members.
Next Wednesday’s webinar, on 24th June, starting at noon will cover “Driving lifestyle behaviour change in diabetes and other lifestyle diseases – at scale“. It will feature Debbie Wake, CEO of My Diabetes My Way, which was an app that blew me away when I was assessing app for the NHS. You can see the full programme for the next few weeks by going here and scrolling down to the bottom.
The discount codes are:
DHACATEN57 for Driving lifestyle behaviour change in diabetes and other chronic diseases – at scale
DHACATEN58 for Improving remote care by monitoring speech
DHACATEN59 for Security, sharing and trust panel discussion
DHACATEN61 for Brainwear: Lessons learned from using patient-recorded data
More vouchers will follow for future events.
These codes are for DHACA members only – I have agreed to audit those using them against our master list of members. If it turns out that they are being misused, the privilege will be removed, so if anyone wants to use one that is not a member yet, please ensure they sign up here, and be sure to tick the box to be signed up for future newsletters!
The RSM is still consulting on preferred time and day of the week – if you prefer other than noon on Wednesdays, let me know.
Talking about past webinars GPonline Daily proudly boasts that the “Proportion of GP consultations delivered within 24 hours surges 50% in COVID-19 pandemic“…however that’s only to 72.8% and “within 24 hours” can mean tomorrow. As we heard in the Total Triage webinar, those patients of surgeries that use triaging systems such as AskmyGP, Klinik and Engage already experience 100% consultation delivery, almost always in the same day.
A change of tone
I’m sensing a change in the approach to digital health just now. Perhaps a straw in the wind is Dr Doctor’s teaming up with Intouch with Health to provide a full secondary care digital pathway encompassing booking and consultation service. This brings together the launch of DrDoctor’s video consultation platform with Intouch’s integrated virtual clinical management suite to help hospitals cope amid the Covid-19 pandemic. The aim is to reduce operational inefficiencies such as authenticating the patient’s identity and matching them to their appointment and doctor. It was always evident that DrDoctor’s eventual goal was much wider than mere appointment booking and indeed CEO Tom Whicher has now essentially transformed his start-up. As Tom says “Beyond the current crisis is a secondary looming threat – the backlog of routine patients who’ve had their care delayed or cancelled. Up to 50% of non-essential care has been cancelled, leaving millions of people waiting for treatment.”
- BusinessCloud’s 100 HealthTech Pioneers ranking for 2020 makes interesting reading – Jean Nehme’s TouchSurgery makes it to top place which is great to see. Down the list, my personal view is that there’s deservedly good recognition for Orcha in the top ten. Less easy to understand is how impressive recent start-up Birdie which featured in a recent DHACA webinar is sandwiched between unicorn Babylon Health and veteran digital health company uMotif halfway down the list. DrDoctor mentioned above doesn’t even get a look-in, and nor does unicorn Huma (recently name changed from Medopad); clearly the listing is not to be taken too seriously.
- I like the Cleveland Clinic’s daily advice emails which often feature the sort of question that I’d want to ask my GP if only i didn’t have a more important question I had to ask. Wednesday’s was particularly rich, with a feature on Computer Vision Syndrome, and how to combat it.
- ‘Digital pill’ maker Proteus Digital Health “filed for bankruptcy” on June 15th marking an important point in the drive to improve medication adherence and delivering an important lesson that no matter how brilliant the technology – and Proteus’s is truly amazing – prosperity depends on real patient need. For many years, I have wondered what the killer application was because it’s so easy to fool (eg by dropping the pill in some lemonade), and the evidence is that the only way to get really good medication adherence is to overcome all concerns patients have such that they want to take the medication. Doubtless once all the outstanding liabilities are removed, and the technology is available much cheaper, there will be a use somewhere – any thoughts dear readers?
- Forbes has calculated the 100 safest countries in the world for Covid-19 – the UK comes 68th, well below below USA at 58 or Russia at 61 – as this week’s Economist says, it’s not our finest hour.
- The DIT has produced a major update to future tech strategy that is essential reading to anyone planning to export goods or services, and very readable too
- A little concern has been expressed at comments made in the fifth reading of this year’s Finance Bill in Parliament about start-ups, however it’s worth noting what HMRC says about its applicability: “Who is likely to be affected: Large multi-national enterprises with revenue derived from the provision of a social media service, a search engine or an online marketplace to UK users.”
- It’s good to see digital health being praised in Parliament – a very short clip for you
- The GSMA has produced a masterful document on contact tracing apps – centralised and decentralised approaches are discussed without comment on pros and cons.
- The MHRA’s support tool to help you decide if your device is a medical device that requires CE Certification has just been updated – well worth checking out.
Thanks as always to Professor Mike Short, and for this newsletter Giovanna Forte and Dr Nicholas Robinson, for pointing out items I might otherwise have missed.